Letter in response to original research article; oral misoprostol solution in comparison to vaginal misoprostol for induction of labour in a randomized controlled trial

Authors

  • Manisha Meena Department of Obstetrics and Gynecology, Post Graduate Institute of Medical Education & Research, Chandigarh, Chandigarh, India
  • Avir Sarkar Department of Obstetrics and Gynecology, Post Graduate Institute of Medical Education & Research, Chandigarh, Chandigarh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20205282

Keywords:

Misoprostol, Labour, RCT

Abstract

We read with great interest the original research article entitled oral misoprostol solution in comparison to vaginal misoprostol for induction of labour in a randomized controlled trial by Abbas et al published in your journal in September 2020 issue. We want to congratulate the authors for this successful research article. It is indeed a great effort to shed light on the choice of preferred route and dose of administration of misorostol as a cervical ripening agent for induction of labour. However, we want to highlight a few points that are worth considering during interpretation of the trial results. All participants recruited in the study were primigravidae at term gestation. While term gestation starts from 37 weeks onwards, but in the inclusion criteria gestation range was mentioned from 36 to 42 weeks.

References

Abbas AM, Thabet PR, Gamrah AEA, El-Kady OS. Oral misoprostol solution in comparison to vaginal misoprostol for induction of labour in a randomized controlled trial. Int J Reprod Contracept Obstet Gynecol. 2020;9(1):3530-6.

Downloads

Published

2020-11-26

Issue

Section

Letter to the Editor